Announced
Completed
Financials
Tags
Cross Border
United Kingdom
Pharmaceuticals
Public
Single Bidder
Private Equity
rare diseases
Friendly
cancer
Acquisition
Majority
Completed
Synopsis
Recordati, an international pharmaceutical group, completed the acquisition of EUSA Pharma, a dynamic, global speciality pharmaceutical company, from EW Healthcare, one of the oldest and most respected healthcare growth equity firms in the world, for $849m. The transaction provides Recordati with an expanded portfolio of rare disease pharmaceutical products.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.